English 
لا توجد منتجات في سلة المشتريات.
TAROLIMUS 0.03% 15 GM OINT
60.00EGP
متوفر في المخزون
| * Indications: Tacrolimus Ointment, for adults, and for children aged 2 to 15 years, is indicated for short-term and |
| & intermittent long-term therapy in the treatment of patients with moderate to severe atopic dermatitis in |
| & whom the use of alternative, conventional therapies are deemed inadvisable because of potential risks, |
| & or in the treatment of patients who are not adequately responsive to or are intolerant of alternative, |
| & conventional therapies. |
| * Dosage and Method of Administration: |
| # Adult: |
| & Apply a thin layer of Tacrolimus Ointment to the affected skin areas twice daily and rub in gently and |
| & completely. Treatment should be continued for one week after clearing of signs and symptoms of atopic |
| & dermatitis. |
| & The safety of Tacrolimus Ointment under occlusion which may promote systemic exposure, has not been |
| & evaluated. Tacrolimus Ointment should not be used with occlusive dressings. |
| # Pediatric: |
| & Apply a thin layer of Tacrolimus Ointment 0.03% to the affected skin areas twice daily and rub in gently |
| & and completely. Treatment should be continued for one week after clearing of signs and symptoms of |
| & atopic dermatitis. he safety of Tacrolimus Ointment under occlusion, which may promote systemic |
| & exposure, has not been evaluated. Tacrolimus Ointment 0.03% should not be used with occlusive |
| & dressings. |
| * Contraindications: |
| & Tacrolimus Ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any |
| & other component of the preparation. |
| * Warnings and precautions: |
| # General: |
| & Studies has not evaluated the safety and efficacy of tacrolimus ointment in the treatment of clinically |
| & infected atopic dermatitis. Before commencing treatment with tacrolimus ointment, clinical infections at |
| & treatment sites should be cleared. |
| & While patients with atopic dermatitis are predisposed to superficial skin infections including eczema |
| & herpeticum (Kaposi’s varicelliform eruption), treatment with Tacrolimus Ointment may be associated with |
| & an increased risk of varicella zoster virus infection (chicken pox or shingles), herpes simplex virus |
| & infection, or eczema herpeticum. In the presence of these infections, the balance of risks and benefits |
| & associated with Tacrolimus Ointment use should be evaluated. |
| & In clinical studies, 33 cases of lymphadenopathy (0.8%) were reported and were usually related to |
| & infections (particularly of the skin) and noted to resolve upon appropriate antibiotic therapy. Of the 33 |
| & cases, the majority had either a clear etiology or were known to resolve. Transplant patients receiving |
| الوزن | 100 kg |
|---|
TACROLIMUS 0.03% (0.3 MG/GM)
منتجات ذات صلة
بدائل البلازما (محاليل الدم)
4.50EGP
غير متوفر في المخزون
مستحضر لعلاج الاكزيما والصدفية
34,757.00EGP
مستحضر لعلاج الاكزيما والصدفية
16.50EGP
غير متوفر في المخزون
دواء يؤثرعلي ايض خلايا السرطان
50.00EGP
